WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 112

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 3'479  3'369  3'250  3'125  2'992  1'906  2'060  1'371 
Births 70  69  67  65  63  44  37  54 
Surviving infants 69  68  67  65  63  44  37  53 
Pop. less than 5 years 333  324  314  301  285  187  235  212 
Pop. less than 15 years 858  835  811  784  754  489  721  548 
Female 15-49 years 850  820  789  757  724  475  547  280 

Number of reported case

(Click for retrospective incidence data for Kuwait)
Diphtheria
Japanese encephalitis
Measles 55  62  27  32  13  71  1'382 
Mumps 76  45  61  62  91  76 
Pertussis 28  30  83  16  41  43  25  69 
Polio* 32 
Rubella 12  13  38  26  87 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 15 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kuwait)
Vaccine year result method % card seen                                                
BCG 1995  26  FHS   75  99  99  97  99  98 
DTP1 1995  94  FHS   75  97  97  97  98  98  97 
DTP3          95  99  98  99  98  98  67 
HepB_BD          96  98  97  98  99  94 
HepB3          96  99  98  99  99  95 
Hib3          95  99  98  99  98  98 
JapEnc         
MCV          94  99*  99  99  98  99  48 
MCV2          86  99  99  99  99 
PCV1          97  97  97  98  98 
PCV3          94  99  99  99*  98 
Pol3          94  99  98  99  98  94  70 
Rota1         
Rota_last         
Rubella1          94  99*  99  99  98 
TT2plus          74  47 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kuwait)
BCG 99  97  99  98 
DTP1 99  99  99  98  98  88  86 
DTP3 99  98  99  98  98  71  67 
HepB3 99  98  99  99  95 
HepB_BD 98  97  98  99  94 
Hib3 99  98  99  98  98 
MCV 99  99  99  98  99  66  48 
MCV2 99  99  99  99 
PAB 95  95  95  95  77  51 
PCV3 99  99  99  98 
Pol3 99  98  99  98  94  71  70 
Rota_last

Number of districts in the country 109  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 5
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
95
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3 months; Yes
DT No where pertussis is contraindicated
DTwP 3.6 years; Yes
DTwPHibHepB 2, 4, 6, 18 months; Yes
HepB birth; Yes and for citizens born after 1990 and health care personnel
IPV 2 months; Yes
Influenza No adults in high risk groups
MMR 12, 24 months; 12 years Yes at 12 years for girls
MenAC No special expatriate working groups
MenACWY 2 years; Yes
OPV 4, 6, 12, 18 months; Yes
Pneumo_conj 2, 4, 6, 18 months; Yes
Pneumo_ps No adults at risk and pilgrims
TT Yes pregnant women and people exposed to accidents
Td 10, 18 years; Yes and school students
Typhoid No food handlers
Varicella No HCW at risk
YF travellers to endemic areas

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes     
What years does the MYP cover? number 2 years  2 YEARS  2013-2014  2 years       
Nº of districts with microplans that include activities to raise immunization coverage number 109  109  109  109  109     

System performance

Total Nº districts in country number 109  109  109  109  109     
Nº districts with DTP3 coverage >=80% number    
% of districts with DTP3 coverage >=80% From 0 to 100%    
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No     

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.